# Patient Opportunity C (LMOPX)

> Source: Nexqual · https://nexqual.com/LMOPX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, Patient Opportunity C (LMOPX), nexqual.com/LMOPX" · informational, not investment advice.

**Price:** USD 47 (-1.59% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 47 · day 47–47 · 52w 38.17–50.53 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +12.4% vs S&P 500 +13.4%; 5Y +38.6% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +12.4% | +38.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +12.5% | +6.8% |
| Volatility (annualized) | 20.6% | 27.3% |
| Max drawdown | -16.0% (Jan 2026→Mar 2026) | -46.3% (Nov 2021→Sep 2022) |

## Peers
LMVTX (ClearBridge Value Trust Cl C) USD 103.21 -0.27% · LMASX (ClearBridge Small Cap Fund Clas) USD 35.07 +0.00% · RYPCX (Royce Pennsylvania Mutual Fund-) USD 7.83 +0.00% · LMGTX (ClearBridge International Growt) USD 57.94 +0.00% · LMGEX (QS International Equity Fund Cl) USD 22 -0.59%

## More
Full page: https://nexqual.com/LMOPX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt